Agonism of the 5-hydroxytryptamine 1f receptor promotes mitochondrial biogenesis and recovery from acute kidney injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 350, Issue 2, 2014, Pages 257-264

  Garrett, Sara M ^a   Whitaker, Ryan M ^a   Beeson, Craig C ^a   Schnellmann, Rick G ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 (4 FLUOROBENZAMIDO) 3 (1 METHYL 4 PIPERIDINYL) 1H INDOLE FUMARATE; MITOCHONDRIAL DNA; N (3 DIMETHYLAMINO 2,3,4,9 TETRAHYDRO 1H CARBAZOL 6 YL) 4 FLUOROBENZAMIDE; SEROTONIN 1F RECEPTOR; SEROTONIN AGONIST;

ACUTE KIDNEY FAILURE; AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOGENESIS; BLOOD FLOW; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; GENE DOSAGE; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ANIMALS; BENZAMIDES; CARBAZOLES; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; FEMALE; FLUOROBENZENES; INDOLES; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OXIDATIVE PHOSPHORYLATION; RABBITS; RECEPTORS, SEROTONIN; REPERFUSION INJURY; SEROTONIN RECEPTOR AGONISTS; TRANSCRIPTION FACTORS;

EID: 84905058536     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.214700     Document Type: Article

References (51)

1. Arany Z, Wagner BK, Ma Y, Chinsomboon J, Laznik D, and Spiegelman BM (2008) Gene expression-based screening identifies microtubule inhibitors as inducers of PGC-1alpha and oxidative phosphorylation. Proc Natl Acad Sci USA 105: 4721-4726.
2. Barnes NM, and Sharp T (1999). A review of central 5-HT receptors and their function. Neuropharmacology, 38:1083-1152.
3. Bayeva M, Gheorghiade M, and Ardehali H (2013) Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol 61:599-610.
4. Beeson CC, Beeson GC, and Schnellmann RG (2010) A high-throughput respirometric assay for mitochondrial biogenesis and toxicity. Anal Biochem 404:75-81 10.1016.
5. Bouchelet I, Case B, Olivier A, and Hamel E (2000) No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery. Br J Pharmacol 129:501-508.
6. Chowanadisai W, Bauerly KA, Tchaparian E, Wong A, Cortopassi GA, and Rucker RB (2010) Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. J Biol Chem 285:142-152.
7. Csiszar A, Labinskyy N, Pinto JT, Ballabh P, Zhang H, Losonczy G, Pearson K, de Cabo R, Pacher P, and Zhang C, et al. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297:H13-H20.
8. Dam AD, Mitchell AS, and Quadrilatero J (2013) Induction of mitochondrial biogenesis protects against caspase-dependent and caspase-independent apoptosis in L6 myoblasts. Biochim Biophys Acta 1833:3426-3435.
9. Di Lisa F, Canton M, Menabò R, Kaludercic N, and Bernardi P (2007) Mitochondria and cardioprotection. Heart Fail Rev 12:249-260.
10. Frier BC, Wan Z, Williams DB, Stefanson AL, and Wright DC (2012) Epinephrine and AICAR-induced PGC-1α mRNA expression is intact in skeletal muscle from rats fed a high-fat diet. Am J Physiol Cell Physiol 302:C1772-1779.
11. Funk JA, Odejinmi S, and Schnellmann RG (2010) SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J Pharmacol Exp Ther 333:593-601.
12. Funk JA and Schnellmann RG (2013) Accelerated recovery of renal mitochondrial and tubule homeostasis with SIRT1/PGC-1α activation following ischemia-reperfusion injury. Toxicol Appl Pharmacol 273:345-354.
13. Havasi A and Borkan SC (2011) Apoptosis and acute kidney injury. Kidney Int 80: 29-40.
14. Hojlund K, Mogensen M, Sahlin K, and Beck-Nielsen H (2008). Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinol Metab Clin North Am 37: 713-731.
15. Jaeschke H, McGill MR, and Ramachandran A (2012) Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metab Rev 44:88-106.
16. Jesinkey SR, Funk JA, Stallons LJ, Wills LP, Megyesi JK, Beeson CC, and Schnellmann RG (2014). Formoterol restores mitochondrial and renal function after ischemia-reperfusion injury. J Am Soc Nephrol DOI: 10.1681/ASN.2013090952 [published ahead of print].
17. Kukidome D, Nishikawa T, Sonoda K, Imoto K, Fujisawa K, Yano M, Motoshima H, Taguchi T, Matsumura T, and Araki E (2006) Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endo-thelial cells. Diabetes 55:120-127.
18. Legrand M, Mik EG, Johannes T, Payen D, and Ince C (2008) Renal hypoxia and dysoxia after reperfusion of the ischemic kidney. Mol Med 14:502-516.
19. Lezi E and Swerdlow RH (2012) Mitochondria in neurodegeneration. Adv Exp Med Biol 942:269-286.
20. Lovenberg TW, Erlander MG, Baron BM, Racke M, Slone AL, Siegel BW, Craft CM, Burns JE, Danielson PE, and Sutcliffe JG (1993) Molecular cloning and functional expression of 5-HT1E-like rat and human 5-hydroxytryptamine receptor genes. Proc Natl Acad Sci USA 90:2184-2188.
21. Lucaites VL, Krushinski JH, Schaus JM, Audia JE, and Nelson DL (2005) [3H]LY334370, a novel radioligand for the 5-HT1F receptor. II. Autoradiographic localization in rat, guinea pig, monkey and human brain. Naunyn Schmiedebergs Arch Pharmacol 371:178-184.
22. Mathai AS, Bonen A, Benton CR, Robinson DL, and Graham TE (2008) Rapid exercise-induced changes in PGC-1alpha mRNA and protein in human skeletal muscle. J Appl Physiol (1985) 105:1098-1105.
23. Mitsikostas DD, and Tfelt-Hansen P (2012) Targeting to 5-HT1F receptor subtype for migraine treatment: lessons from the past, implications for the future. Cent Nerv Syst Agents Med Chem 12:241-249.
24. Monsalve M, Borniquel S, Valle I, and Lamas S (2007) Mitochondrial dysfunction in human pathologies. Front Biosci 12:1131-1153.
25. Mudò G, Mäkelä J, Di Liberto V, Tselykh TV, Olivieri M, Piepponen P, Eriksson O, Mälkiä A, Bonomo A, and Kairisalo M, et al. (2012) Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease. Cell Mol Life Sci 69:1153-1165.
26. Nichols DE and Nichols CD (2008) Serotonin receptors. Chem Rev 108:1614-1641.
27. Nowak G and Schnellmann RG (1995) Improved culture conditions stimulate gluconeogenesis in primary cultures of renal proximal tubule cells. Am J Physiol 268: C1053-C1061.
28. Pagel-Langenickel I, Bao J, Joseph JJ, Schwartz DR, Mantell BS, Xu X, Raghavachari N, and Sack MN (2008) PGC-1alpha integrates insulin signaling, mitochondrial regulation, and bioenergetic function in skeletal muscle. J Biol Chem 283:22464-22472.
29. Pardo R, Enquix N, Lasheras J, Feliu JE, Kralli A, and Villena JA (2011) Rosiglitazone-induced mitochondrial biogenesis in white adipose tissue is independent of peroxisome proliferator-activated receptor g coactivator- 1α. PLoS One 6:e26989.
30. Pessayre D, Fromenty B, Berson A, Robin MA, Lettéron P, Moreau R, and Mansouri A (2012) Central role of mitochondria in drug-induced liver injury. Drug Metab Rev 44:34-87.
31. Peterson YK, Cameron RB, Wills LP, Trager RE, Lindsey CC, Beeson CC, and Schnellmann RG (2013) β2-Adrenoceptor agonists in the regulation of mitochondrial biogenesis. Bioorg Med Chem Lett 23:5376-5381.
32. Phebus LA, Johnson KW, Zgombick JM, Gilbert PJ, Van Belle K, Mancuso V, Nelson DL, Calligaro DO, Kiefer AD Jr, and Branchek DA, et al. (1997). Characterization of LY344864 as a pharmacological tool to study 5-HT1F receptors: binding affinities, brain penetration and activity in the neurogenic dural inflammation model of migraine. Life Sci 61:2117-2126.
33. Ramadan NM, Skljarevski V, Phebus LA, and Johnson KW (2003) 5-HT1F receptor agonists in acute migraine treatment: a hypothesis. Cephalalgia 23:776-785.
34. Rasbach KA, Funk JA, Jayavelu T, Green PT, and Schnellmann RG (2010) 5-Hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J Pharmacol Exp Ther 332:632-639.
35. Rasbach KA and Schnellmann RG (2008) Isoflavones promote mitochondrial biogenesis. J Pharmacol Exp Ther 325:536-543.
36. Robertson CL (2004) Mitochondrial dysfunction contributes to cell death following traumatic brain injury in adult and immature animals. J Bioenerg Biomembr 36: 363-368.
37. Romanino K, Mazelin L, Albert V, Conjard-Duplany A, Lin S, Bentzinger CF, Handschin C, Puigserver P, Zorzato F, and Schaeffer L, et al. (2011) Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function. Proc Natl Acad Sci USA 108: 20808-20813.
38. Scarpulla RC, Vega RB, and Kelly DP (2012) Transcriptional integration of mito-chondrial biogenesis. Trends Endocrinol Metab 23:459-466.
39. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, Zhang J, Soden R, Hayakawa M, and Kreiman G, et al. (2004) A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 101:6062-6067.
40. Sweeney TE, Suliman HB, Hollingsworth JW, and Piantadosi CA (2010) Differential regulation of the PGC family of genes in a mouse model of Staphylococcus aureus sepsis. PLoS ONE 5:e11606.
41. Tsunemi T, Ashe TD, Morrison BE, Soriano KR, Au J, Roque RA, Lazarowski ER, Damian VA, Masliah E, and La Spada AR (2012) PGC-1α rescues Huntington's disease proteotoxicity by preventing oxidative stress and promoting TFEB function. Sci Transl Med 4:142ra197.
42. Tsunemi T and La Spada AR (2012) PGC-1α at the intersection of bioenergetics regulation and neuron function: from Huntington's disease to Parkinson's disease and beyond. Prog Neurobiol 97:142-151.
43. Ventura-Clapier R, Garnier A, and Veksler V (2008) Transcriptional control of mitochondrial biogenesis: the central role of PGC-1alpha. Cardiovasc Res 79:208-217.
44. Wenz T (2009) PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life 61:1051-1062.
45. Wenz T, Diaz F, Spiegelman BM, and Moraes CT (2008) Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mito-chondrial myopathy phenotype. Cell Metab 8:249-256.
46. Whitaker RM, Wills LP, Stallons LJ, and Schnellmann RG (2013) cGMP-selective phosphodiesterase inhibitors stimulate mitochondrial biogenesis and promote recovery from acute kidney injury. J Pharmacol Exp Ther 347:626-634.
47. Williams DB, Sutherland LN, Bomhof MR, Basaraba SA, Thrush AB, Dyck DJ, Field CJ, and Wright DC (2009) Muscle-specific differences in the response of mito-chondrial proteins to beta-GPA feeding: an evaluation of potential mechanisms. Am J Physiol Endocrinol Metab 296:E1400-E1408.
48. Wills LP, Trager RE, Beeson GC, Lindsey CC, Peterson YK, Beeson CC, and Schnellmann RG (2012) The β2-adrenoceptor agonist formoterol stimulates mitochondrial biogenesis. J Pharmacol Exp Ther 342:106-118.
49. Xu J, Yao B, Fan X, Langworthy MM, Zhang MZ, and Harris RC (2007) Characterization of a putative intrarenal serotonergic system. Am J Physiol Renal Physiol, 293:F1468-1475.
50. Yatsuga S and Suomalainen A (2012) Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice. Hum Mol Genet 21:526-535.
51. Zhuang S, Lu B, Daubert RA, Chavin KD, Wang L, and Schnellmann RG (2009) Suramin promotes recovery from renal ischemia/reperfusion injury in mice. Kidney Int 75:304-311.